{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:18:12Z","timestamp":1787509092447,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.7759\/cureus.81330","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:40:04Z","timestamp":1743133204000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females"],"prefix":"10.7759","author":[{"given":"Raji","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Dhoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiprasad","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmant","family":"Barkate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15961","article-title":"Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis","volume":"35","author":"dos Santos-Neto AG","year":"2022","unstructured":"dos Santos-Neto AG, da Silva \u00cdC, Melo CR, Santana AA, de Albuquerque-Junior RL. Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis. Dermatol Ther. 2022, 35:e15961. 10.1111\/dth.15961","journal-title":"Dermatol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.05748.x","article-title":"Epidemiology of melasma in Brazilian patients: a multicenter study","volume":"53","author":"Hexsel D","year":"2014","unstructured":"Hexsel D, Lacerda DA, Cavalcante AS, et al.. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014, 53:440-4. 10.1111\/j.1365-4632.2012.05748.x","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15566","article-title":"Efficacy and safety of topical agents in the treatment of melasma: what's evidence? A systematic review and meta-analysis","volume":"22","author":"Chang YF","year":"2023","unstructured":"Chang YF, Lee TL, Oyerinde O, et al.. Efficacy and safety of topical agents in the treatment of melasma: what's evidence? A systematic review and meta-analysis. J Cosmet Dermatol. 2023, 22:1168-76. 10.1111\/jocd.15566","journal-title":"J Cosmet Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00488-w","article-title":"Melasma treatment: an evidence-based review","volume":"21","author":"McKesey J","year":"2020","unstructured":"McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020, 21:173-225. 10.1007\/s40257-019-00488-w","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.09.006","article-title":"The dark side of skin lightening: an international collaboration and review of a public health issue affecting dermatology","volume":"7","author":"Pollock S","year":"2021","unstructured":"Pollock S, Taylor S, Oyerinde O, et al.. The dark side of skin lightening: an international collaboration and review of a public health issue affecting dermatology. Int J Womens Dermatol. 2021, 7:158-64. 10.1016\/j.ijwd.2020.09.006","journal-title":"Int J Womens Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15878","article-title":"Exogenous ochronosis associated with hydroquinone: a systematic review","volume":"61","author":"Ishack S","year":"2022","unstructured":"Ishack S, Lipner SR. Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2022, 61:675-84. 10.1111\/ijd.15878","journal-title":"Int J Dermatol"},{"key":"ref7","article-title":"Skin changes and safety profile of topical products during pregnancy","volume":"15","author":"Putra IB","year":"2022","unstructured":"Putra IB, Jusuf NK, Dewi NK. Skin changes and safety profile of topical products during pregnancy. J Clin Aesthet Dermatol. 2022, 15:49-57.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200910040-00005","article-title":"The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review","volume":"10","author":"Kang HY","year":"2009","unstructured":"Kang HY, Valerio L, Bahadoran P, Ortonne JP. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009, 10:251-60. 10.2165\/00128071-200910040-00005","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","volume":"22","author":"Kang HY","year":"2010","unstructured":"Kang HY, Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol. 2010, 22:373-8. 10.5021\/ad.2010.22.4.373","journal-title":"Ann Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2011.630088","article-title":"Melasma: treatment strategy","volume":"13","author":"Sehgal VN","year":"2011","unstructured":"Sehgal VN, Verma P, Srivastava G, Aggarwal AK, Verma S. Melasma: treatment strategy. J Cosmet Laser Ther. 2011, 13:265-79. 10.3109\/14764172.2011.630088","journal-title":"J Cosmet Laser Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.100134","article-title":"Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma","volume":"1","author":"Iraji F","year":"2012","unstructured":"Iraji F, Tagmirriahi N, Gavidnia K. Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma. Adv Biomed Res. 2012, 1:39. 10.4103\/2277-9175.100134","journal-title":"Adv Biomed Res"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_19_19","article-title":"Comparative study of efficacy of intradermal tranexamic acid versus topical tranexamic acid versus triple combination in melasma","volume":"6","author":"Patil SS","year":"2019","unstructured":"Patil SS, Deshmukh AR. Comparative study of efficacy of intradermal tranexamic acid versus topical tranexamic acid versus triple combination in melasma. Pigment Int. 2019, 6:84-95.","journal-title":"Pigment Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.051","article-title":"Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method","volume":"64","author":"Pandya AG","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R, et al.. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011, 64:78-83.E2. 10.1016\/j.jaad.2009.10.051","journal-title":"J Am Acad Dermatol"},{"key":"ref14","unstructured":"Courage + Khazaka Electronic. Mexameter\u00ae MX 18. (2018). Accessed: March 11, 2025: https:\/\/www.courage-khazaka.com\/en\/scientific-products\/occupational-health\/occupational-health\/169-mexameter-e."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.108070","article-title":"A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma","volume":"58","author":"Monteiro RC","year":"2013","unstructured":"Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013, 58:157. 10.4103\/0019-5154.108070","journal-title":"Indian J Dermatol"},{"key":"ref16","article-title":"Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety","volume":"58","author":"Deo KS","year":"2013","unstructured":"Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013, 58:281-5.","journal-title":"Indian J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman AM","year":"1975","unstructured":"Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975, 111:40-8.","journal-title":"Arch Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14494","article-title":"Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review","volume":"20","author":"Ahramiyanpour N","year":"2021","unstructured":"Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A. Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. J Cosmet Dermatol. 2021, 20:3593-602. 10.1111\/jocd.14494","journal-title":"J Cosmet Dermatol"},{"key":"ref19","article-title":"Topical treatments for melasma: a systematic review of randomized controlled trials","volume":"18","author":"Austin E","year":"2019","unstructured":"Austin E, Nguyen JK, Jagdeo J. Topical treatments for melasma: a systematic review of randomized controlled trials. J Drugs Dermatol. 2019, 18:1156-71.","journal-title":"J Drugs Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.110089","article-title":"Cosmeceuticals for hyperpigmentation: what is available?","volume":"6","author":"Sarkar R","year":"2013","unstructured":"Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available?. J Cutan Aesthet Surg. 2013, 6:4-11. 10.4103\/0974-2077.110089","journal-title":"J Cutan Aesthet Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1995.tb00669.x","article-title":"Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase","volume":"8","author":"Kahn V","year":"1995","unstructured":"Kahn V. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase. Pigment Cell Res. 1995, 8:234-40. 10.1111\/j.1600-0749.1995.tb00669.x","journal-title":"Pigment Cell Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S372456","article-title":"Melasma: a step-by-step approach towards a multimodal combination therapy","volume":"17","author":"Philipp-Dormston WG","year":"2024","unstructured":"Philipp-Dormston WG. Melasma: a step-by-step approach towards a multimodal combination therapy. Clin Cosmet Investig Dermatol. 2024, 17:1203-16. 10.2147\/CCID.S372456","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15146","article-title":"A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women","volume":"59","author":"Lima PB","year":"2020","unstructured":"Lima PB, Dias JA, Cassiano D, Esposito AC, Bagatin E, Miot LD, Miot HA. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women. Int J Dermatol. 2020, 59:1531-6. 10.1111\/ijd.15146","journal-title":"Int J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02133-7","article-title":"Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study","volume":"313","author":"Karrabi M","year":"2021","unstructured":"Karrabi M, Mansournia MA, Sharestanaki E, Abdollahnejad Y, Sahebkar M. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study. Arch Dermatol Res. 2021, 313:539-47. 10.1007\/s00403-020-02133-7","journal-title":"Arch Dermatol Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12901","article-title":"Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: a randomized, double-blind clinical trial study","volume":"27","author":"Karrabi M","year":"2021","unstructured":"Karrabi M, David J, Sahebkar M. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: a randomized, double-blind clinical trial study. Skin Res Technol. 2021, 27:24-31. 10.1111\/srt.12901","journal-title":"Skin Res Technol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1351608","article-title":"Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study","volume":"29","author":"Farshi S","year":"2018","unstructured":"Farshi S, Mansouri P, Kasraee B. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study. J Dermatolog Treat. 2018, 29:182-9. 10.1080\/09546634.2017.1351608","journal-title":"J Dermatolog Treat"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13424","article-title":"Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial","volume":"173","author":"Mansouri P","year":"2015","unstructured":"Mansouri P, Farshi S, Hashemi Z, Kasraee B. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol. 2015, 173:209-17. 10.1111\/bjd.13424","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13432","article-title":"Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: a randomised, double-blinded trial","volume":"62","author":"Nguyen J","year":"2021","unstructured":"Nguyen J, Remyn L, Chung IY, et al.. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: a randomised, double-blinded trial. Australas J Dermatol. 2021, 62:e41-6. 10.1111\/ajd.13432","journal-title":"Australas J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12109","article-title":"Discrimination between cutaneous pigmentation and erythema: comparison of the skin colorimeters Dermacatch and Mexameter","volume":"20","author":"Baqui\u00e9 M","year":"2014","unstructured":"Baqui\u00e9 M, Kasraee B. Discrimination between cutaneous pigmentation and erythema: comparison of the skin colorimeters Dermacatch and Mexameter. Skin Res Technol. 2014, 20:218-27. 10.1111\/srt.12109","journal-title":"Skin Res Technol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352125-comparison-of-the-effectiveness-and-safety-of-5-cysteamine-and-2-kojic-acid-creams-in-the-treatment-of-melasma-in-indian-adult-females","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:40:25Z","timestamp":1743133225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352125-comparison-of-the-effectiveness-and-safety-of-5-cysteamine-and-2-kojic-acid-creams-in-the-treatment-of-melasma-in-indian-adult-females"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.81330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}